Advertisement
Research Article

Diversity and Recognition Efficiency of T Cell Responses to Cancer

  • Tor B Stuge,

    Affiliation: Department of Medicine, Division of Hematology, Stanford University, Stanford, California, United States of America

    X
  • Susan P Holmes,

    Affiliation: Department of Statistics, Stanford University, Stanford, California, United States of America

    X
  • Sahdev Saharan,

    Affiliation: Department of Medicine, Division of Hematology, Stanford University, Stanford, California, United States of America

    X
  • Andrea Tuettenberg,

    Affiliation: Department of Dermatology, J. Gutenberg-University, Mainz, Germany

    X
  • Mario Roederer,

    Affiliation: ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Jeffrey S Weber,

    Affiliation: Norris Cancer Center, University of Southern California, Los Angeles, California, United States of America

    X
  • Peter P Lee

    Affiliation: Department of Medicine, Division of Hematology, Stanford University, Stanford, California, United States of America

    X
  • Published: November 30, 2004
  • DOI: 10.1371/journal.pmed.0010028

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

The Quest for a Vaccine That Yields Tumor-Killing T cells

Synopsis | published 30 Nov 2004 | PLOS Medicine
doi:10.1371/journal.pmed.0010050

Using Modified Antigenic Sequences to Develop Cancer Vaccines: Are We Losing the Focus?

Danila Valmori, Maha Ayyoub
Perspective | published 30 Nov 2004 | PLOS Medicine
doi:10.1371/journal.pmed.0010026